, respectively, at the beginning of, during, and after the transmission season of malaria. The clinical longitudinal study during the transmission period allowed us to define three different groups in terms of both age and occurrence of malaria attack (5,000 Plasmodium falciparum per mm3 of blood and axillary fever of >37.rC) as follows: group 1, persons .15 years old who had at least one malaria attack during the transmission period; group 2, individuals '15 years old who did not have any malaria attacks; and group 3, individuals considered to be protected (adults > 15 years old with no malaria attacks). Soluble interleukin-2 receptor (sIL-2R) levels were found to be significantly increased (P < 0.001) in the first two groups (1,047 481 U/ml [mean standard deviation]) as compared with the adult group (605 ± 307 U/ml). Considering all the groups, no significant difference was observed between observation periods. Levels of sIL-2R were inversely correlated (r = -0.39, n = 237, P < 0.01) with age (range, 4 to 67 years). Negative correlations were also noticed between the levels of sIL-2R and those of antibodies to somatic antigen of P. falkiparum (immunoglobulin G [IgG] class [r = -0.33, n = 237, P < 0.01] and IgM class [r = -0.20, n = 237, P < 0.05]). IgG antibody levels to somatic antigen were correlated with age, but IgM antibody levels to somatic antigen were not. The possible role played by sIL-2R in effector mechanisms against malaria is discussed.
Interleukin-2 (IL-2), previously described as T-cell growth factor (21) , is a polypeptide of an apparent relative molecular weight (Mr) of 15, 500 . It is produced and secreted by T cenls, activated NK cells, or large granular lymphocytes during the first hours following stimulation by a mitogen or an antigen. IL-2 is considered to play a pivotal role in the regulation of the immune response. Activated T ceils (2) as well as activated B ceils (14, 19) express specific IL-2 receptors (IL-2Rs) on their surfaces. IL-2Rs can exist on the ceil surface in three different forms as follows: (i) a heterodimer of high affinity composed of two chains; (ii) a chain called "a," also known as p75, with an Mr of 70,000 to 75,000 (27) ; and (iii) a second chain called ",B," or p55, with an Mr of 55,000 (17) . These forms have different affinities (a[3 > a > for IL-2 (33) . The a-chain probably mediates internalization of membrane-bound ligand and gives the signal for growth transduction (34) , and the [B-chain probably faciitates the formation of the a[ heterodimer. After activation, both T and B cells release a stable, soluble small form of the [-chain (sIL-2R [soluble interleukin-2 receptor]) which can be found in plasma, sera, or urine (25) .
Both the cellular and humoral immune responses against malaria parasites are mainly regulated by the T-cell system (for a review, see references 12 and 31). In (16) . The immunofluorescent-antibody test was performed as described elsewhere (P. Ambroise-Thomas, Ph.D. thesis, Lyon University, Lyon, France, 1969) by using'parasitized erythrocytes at the 'schizont stage. Conjugated rabbit anti-human immunoglobulin G'(IgG) and rabbit'anti-human IgM labeled with fluorescein were used (Institut Pasteur, Paris, France). The positive cutoffs for IgG and IgM antibody levels to P. falciparum schizonts were fixed at 1:80 and 1:20, respectively.
Enzyme-linked immunosorbent assay. Somatic antigen (Somn-Ag) was prepared by controlled lysis of parasitized erythrocytes (schizont stage), ultrasonication, and centrifugation (29, 35) . The Som-Ags were mainly soluble cytoplasmic antigens with some surface components.
Antibodies to Som-Ag were detected by a micro-enzymelinked immunosorbent assay (28) . Phosphate-buffered saline supplemented with 0.05% Tween 20-5% dry skim milk was used for dilution of plasma and conjugates. Conjugates considered to be protected (no malaria attacks during the transmission season).
As the Dafinso group of subjects was similar to that of Vallée du Kou in age, sex, socioeconomic factors, and frequency of malarial attacks, the groups were analyzed together.
Parasitological findings. The parasitological findings are described according to age, occurrence of clinically detectable malaria attacks in groups 1 to 3, and observation periods (passages) ( Table 1) . Considering all groups, 15.6% of slides were positive in June (passage A), 56.1% were positive in August to September (passage B), and 28.4% were positive in January (passage C). From passage B to C, the prevalence of positive slides decreased in group 1 and increased slightly in groups 2 and 3.
The highest average levels of parasitemia were observed in group 1 in June (12,960 ± 18,120 parasites per mm3) and in August to September (27,450 ± 64,340 parasites per mm3).
The average densities of P. falciparum were low in January and comparable between groups 1 (320 ± 760) and 2 (630 ± 1,400) but different in group 3 (70 ± 190).
Antibodies to P. falciparum. The prevalence rates of antibodies to P. falciparum are shown in Fig. 1 .
IgG antibodies to Som-Ag. On the basis of analysis of variance of A492, a significant difference (P < 0.01) was observed between group 3 (A492 = 0.49) and the other two groups (A492 = 0.23). Furthermore, A492 was correlated with age (r = 0.50, n = 237, P < 0.01). IgG antibodies to the P. falciparum schizont stage. On the basis of analysis of variance of the logarithm of the titers for all passages, significant differences (P < 0.001) were noticed between groups 1 and 3 (3 > 1) and 2 and 3 (3 > 2). When all groups were considered, significant differences (P < 0.01) were also observed, but to a lesser extent, between passages (B > A; C > A).
IgM antibodies to Som-Ag. IgM antibodies were more frequently detected in persons who had not had any malaria attack (58.7% for group 3 and 51.7% for group 2) than in those who had had at least one attack (29.6%; P < 0.01). Considering A492 in all the observation periods, significant differences (P < 0.001) were obtained between group 3 (mean, 0.54) and the other two groups (mean, 0.42). No correlation was observed with age (r = 0.17, n = 237, P-0.05). In addition, when the whole population studied was analyzed, significant differences were found between passages B and C (B < C; P < 0.05) and between A and C (A < C; P < 0.001).
IgM antibodies to the P. falciparum schizont stage. Considering the logarithm of the titers for all passages, significant differences between groups 1 and 3 (3 > 1; P < 0.01) and between groups 2 and 3 (3 > 2; P < 0.05) were observed. In addition, when all the groups were analyzed together, a significant difference (P < 0.02) was observed between passages A and C (C > A).
sIL-2R. Considering all of the investigated population, the prevalence rates of sIL-2R (-1,000 U/ml) were 25.3% in June, 27.7% in August to September, and 28.4% in January (Fig. 1) . In passage B, 56% of plasma samples were significantly positive for group 1, 48% were positive for group 2, and 7% were positive for group 3 period, they were almost stable for the last two groups. Nevertheless, in group 1, the prevalence rates of sIL-2R increased from passage A (33.3%) to B (56%) and remained stable from B to C (55.6%). The variations in the average level of sIL-2R in plasma in relation to passages and groups are indicated in Fig. 2 . Individuals <16 years old (groups 1 and 2) showed increased levels of sIL-2R (1,047 + 481 U/ml). No significant difference in the average level of sIL-2R was observed in group 1 from passage A (902 U/ml) to B (1,153 U/ml) and from B to C (1,033 U/ml). Nevertheless, significant differences (P < 0.001) were observed between groups 3 and the other two groups (3 < 2 c 1). Group 3 showed the lowest levels of sIL-2R (605 + 307 U/ml).
No correlation was observed between parasitemia and sIL-2R titers. Nevertheless, negative correlations between levels of sIL-2R and antibody titers to Som-Ag (IgG class, r = -0.33, n = 237, P < 0.01; IgM class, r = -0.20, n = 237, P < 0.05) were observed. The variations of sIL-2R levels according to antibody titers of IgG to Som-Ag are shown in Fig. 3 .
DISCUSSION
The main finding of this work was that high levels of sIL-2R were mainly found in individuals who have not acquired premunition status against malaria. In addition, sIL-2R levels were inversely correlated to the levels of antibodies to Som-Ag. Levels of IgG antibodies were also found to be correlated with age (range, 4 to 67 years old), as previously reported by Gazin et al. (8) in the Sahel area of Oudalan (Burkina Faso) in school children from 1 to 15 years old.
Our data on prevalence rates of IgG antibodies to Som-Ag suggested that they could be used as evidence for a very long-term malarial infection because they were found in 48% of adults (group 3) and only in 11.7% of the children in group 2, who did not have any malaria attacks during the transmission period. However, in our study, in contrast to previous data reported by Molineaux and Gramiccia (20) , IgM antibody levels were not found to be correlated with age. The use of different antigens and the number of analyzed persons could explain this discrepancy. Moreover, IgM antibodies to Som-Ag were found with a similar positive rate in both the adults and group 2 children.
The evolution of IgG antibody levels to the P. falciparum schizont stage paralleled the parasitemia from passage A (beginning of the transmission period) to B (during). Nevertheless, parasitemia in children remains a good marker for determining and following the transmission period in a population living in an endemic area of malaria.
In this study, increased levels of sIL-2R were observed in groups 1 (age, s15 years, with at least one malaria attack) and 2 (comparable to group 1 but without any malaria attacks). Our findings were in agreement with previous reports (6, 10, 12) , although our increased levels were not always associated with detectable symptoms of clinical malaria (group 2). Similar results were also described by Nguyen-Dinh and Greenberg (22) . An explanation for this could be the development of chronic malaria (continuous antigenic stimulation may up-regulate expression and release of IL-2R) and/or the presence of concomitant infections such as schistosiomasis (12) .
In the region near Bobo-Dioulasso, it is well established that protection against malaria is acquired after 15 years of age (1, 8) . In this survey, significant differences of sIL-2R levels were observed between group 3 (adults >15 years old without any malaria attack) and group 1 or 2 (<15 years old). However, these findings cannot be interpreted as being correlated to the expected protection from malaria because sIL-2R may vary per se as a function of age. As a matter of fact, Kloster et al. (13) and Nguyen-Dinh and Greenberg (22) have reported higher levels of sIL-2R in children than in adults. This point was recently clarified by Deloron et al. (6) in a malaria hypoendemic region near Antananarivo, Madagascar, where malaria attacks were diagnosed in children as well as in adults. Increased levels of sIL-2R were found at the moment of the malaria infection in all the cases. Therefore, increased levels of sIL-2R found in groups 1 and 2 might be due to age but also to concomitant malaria infections.
Any significant variation in sIL-2R levels or rates was observed between passages, as was observed for subsets of peripheral activated T (CD3+ HLA DR+) and B (CD3-HLA DR+) cells (23) . This lack of variation may be due to the fact that after a malaria attack, sIL-2R levels declined strongly from 2 (5, 6) to 6 (11) weeks. Therefore, in this mesoendemic region, sIL-2R can not be used as a marker of the malaria transmission season, as was found for tumor necrosis factor in the same area and transmission period (24) .
In this study, sIL-2R levels were negatively correlated with IgG and IgM antibodies to Som-Ag of P. falciparum. Josimovic-Alasevic et al. (12) have postulated that the exuberant expression and release of IL-2R were mainly due to B à à lymphocytes rather than T cells. High levels of sIL-2R were also noticed in this study in both symptomatic and asymptomatic patients (groups 1 and 2). This overproduction of sIL-2R could be regulated by T cells via the production of interleukin. In fact, IL-4 regulates expression ofthe a-chain (p75) and IL-5 controls expression of the 3-chain (p55) on B cells (19) . Therefore, in our study the increased levels of the soluble 3-chain might be due to an overproduction of IL-5 or to a decreased production of IL-4. This could prevent the formation on B cells of the highly efficient aB receptor for IL-2. Alternatively, we could suggest a down-regulated function for the sIL-2R at high levels on B cells producing antibodies directly or indirectly. A direct negative B-cell regulation has not been observed. Instead, an indirect negative regulation is more likely because immunity to malaria is mainly regulated by the T-cell system and there is reported evidence for a down regulation of T-cell growth by the ,B-chain (15) . This might play a crucial role in the immunosuppression frequently observed in patients during the acute phase of malaria, in which increased levels of sIL-2R were also observed (11) . Therefore, the time range in which sIL-2R could have beneficial or negative effects like those reported for tumor necrosis factor (9) remains to be determined.
